Background: Access to antiretroviral treatment (ART) has improved greatly in many parts of the world, including Uganda, yet, many patients delay to start ART even when registered within the HIV services. We assessed, in a routine ambulatory care setting, what proportion of patients start ART late and the associated factors.
tiating ART early improves survival rates and immunological [3] [4] [5] [6] [7] [8] [9] (range, 1-505). Thirty-one patients (10%) were in World Health Organization stage 4. One hundred twenty-three patients (37.7%) were and clinical outcomes. onward transmission. 10 Early initiation of ART also reduces In patients who start ART late, often initiated on ART with CD4 cells ,100 cells/mL. Being male [adjusted OR (aOR): 2.4; 95% confidence interval: 1.3 to 4.2, P = 0.002] and opportunistic infections need to be taken care of before initiating ART, calling for careful tailoring of ART to the individual 11 having no employment (aOR: 1.9; 95% confidence interval: 1.2 to 3.3, patient needs. Late start of treatment may also be complicated P = 0.012) were associated with late start of ART. Being older, being by immune reconstitution inflammatory syndrome. results in additional costs to the health services. In Uganda, a high proportion (.40%) of patients have been reported to present at ART clinics with severe immune suppression. 15, 16 World Health Organization (WHO) clinical stage 4 disease has been identified as a strong risk factor for death among HIV patients before treatment and in treatment. 17 Several studies have identified demographic and other risk factors for advanced disease stage at the time of ART initiation. 18, 19 Most of these studies have been done at research clinics, university teaching hospitals, and nongovernmental organizations, and these results may not be generalizable to routine under-resourced health services in public primary health care settings. These studies focused on patients accessing HIV care services late (with advanced disease), but analyses of late start of ART once registered within the HIV services were largely lacking. The objectives of this study were to assess in urban primary care-settings in Kampala, Uganda, the proportion of patients starting ART late and the factors associated with this late start.
METHODS

Study Setting
The study was conducted between May 2008 and August 2009 among ART-naive patients at 3 of the 10 public primary health care facilities operated by Kampala Capital City Authority, offering outpatient services, including HIV diagnosis, care and treatment free of charge. 20 The 3 centers were purposefully chosen considering geographical representation for a semirural residential area (Kiruddu), a densely populated low-income area (Kisenyi), and an industrial urban area (Kiswa). The health centers are faced with heavy patient load, understaffing, and periodic stock-outs of commodities.
In the health centers, ART clinics were conducted twice weekly and managed through teams headed by a clinical officer or medical doctor. HIV patients were identified by the following means: (1) routine testing and counseling at outpatient department, (2) prevention of mother-to-child transmission of HIV services at maternal and child health clinics, (3) referrals from community-based organizations, or (4) individual patient walk-in. Rapid HIV tests were performed according to a serial algorithm recommended by the Uganda Ministry of Health. 21 For patients whose initial HIV diagnosis was made elsewhere, HIV testing was repeated at the health center.
Patients for whom the rapid HIV tests were positive were booked in a pre-ART register (enrolment into HIV care) and co-trimoxazole or diamino-diphenyl sulfone prophylaxis was prescribed immediately. The patient was then given a clinic appointment for counseling and a CD4 count. Blood samples were transferred to a certified laboratory for a confirmatory HIV test (ELISA). Results were obtained generally within 1 week. ART eligibility was determined based on CD4 count ,200 cells/mL or WHO stage 4 in accordance with Ugandan guidelines prevailing at the time of the study. The decision to actually start ART depended on the patient's identification of a treatment supporter and the counselor's assessment that the patient would be adherent to treatment. Usually 2 or 3 counseling sessions were required before starting ART. Comprehensive HIV care was offered in accordance with the national treatment guidelines in place at the time of the study, adapted from the WHO guidelines. 22 
Study Design
Patients aged 18 years or older, ART naive, and newly registered for treatment at the 3 Kampala Capital City Authority clinics were consecutively recruited into the cohort. Interviews were administered by trained staff using a pretested semistructured questionnaire on the day that the clinician prescribed start of ART or one day later (see Supplemental Digital Content, http://links.lww.com/QAI/A349). The questionnaire was translated into Luganda and back-translated into English to ensure consistency. Data were collected on patients' socioeconomic and demographic characteristics. Clinical data, including HIV status confirmation, WHO clinical staging, most recent CD4 count, date of CD4 test, participant having a treatment supporter, patient attached to a support group, type of support group, functional status, weight, height, other tests done, ART regimen, prophylaxis, provision of a basic kit, and HIV status disclosure were extracted from the patients' medical files. The study team was present at set weekdays at each clinic. Patients who attended the HIV clinic on nonstudy days could not be enrolled. Exclusion criteria were previous exposure to ART (with exception of a single-dose nevirapine) and residence outside Kampala district or beyond a 16-km radius from the city center.
Data Handling and Statistical Analysis
Data were double entered into OpenClinica software (Akaza Research, Waltham, MA) and checked for inconsistencies. Statistical analyses were carried out using Stata v10 (StataCorp, College Station, TX).
Body mass index (killograms per square meter) was categorized according to the WHO International Classification of Adult body mass index. 23 Household wealth was derived from asset scores as applied in health, nutrition, and poverty studies and categorized into tertiles. 24 Alcohol consumption was assessed using 4 question items from the "CAGE" questionnaire, which is a screening tool used to detect patients who may require further assessment for alcohol dependence. 25 Two positive responses were considered a positive test for heavy alcohol consumption. Functional performance was assessed using the Working, Ambulatory, and Bedridden scoring system. 26 The outcome of interest in this study was late start of ART defined as starting ART at very low CD4 count ,100 cells/mL. In the univariable analysis, we explored factors identified in earlier studies as associated with delay. Multivariable logistic regression was used to identify factors that were independently associated with late start of ART. Age, sex, and distance from residence to health center were forced in to the model. We entered in the models clinical, demographic, and socioeconomic variables if they showed an association in the univariate analysis at P , 0.25, and kept them in the final model if they contributed to the model likelihood at P , 0.05, or confounded the association between outcome and any of the other variables in the model. We performed 2 secondary multivariable analyses, one restricting the primary analysis to patients who met the Ugandan ART eligibility criteria, the other restricting it to patients who initiated ART within 28 days of having been identified as eligible for ART.
Ethical Review
This study received ethical approval from the Medical Ethics Committees of Makerere University School of Public Health and the Academic Medical Center, Amsterdam. Written informed consent was obtained from all participants.
RESULTS
During the study period, 436 patients were screened for participation in the cohort of whom 33 did not meet the inclusion criteria, 33 declined consent, and 4 visited outside the study days (Fig. 1) . The patients who declined consent and those who missed were more often women (P = 0.687), younger (P = 0.049), and had higher CD4 counts (P = 0.067). Of the 366 patients recruited, 326 (89%) started ART during the study period. The 40 patients who did not start ART had higher median CD4 cell counts (162 cells/mL) compared with those who started treatment (132 cells/mL, P = 0.006), had lower Karnofsky score (P , 0.001), and were more often unemployed (51% versus 31%, P = 0.011, Table 1 ). The time interval from the patient's date of enrolment into the study until the censoring date (=last date of recruitment) was not significantly different between the 2 groups (P = 0.378).
The median age of the patients who started treatment was 34 years (range, 18-71); 218 (67%) were women ( Table  1 ). The median interval from time of entering into HIV care program to start of ART was 105 days (interquartile range: 70-231). The median time between being considered eligible for ART by the clinician and actual start of treatment was 8 days (interquartile range: 0-28). Seventy patients (22%) were underweight.
At the time of starting ART, 272 (83%) of 326 patients fulfilled the Ugandan criteria for ART eligibility; 54 (17%) patients did not. One hundred twenty-three patients starting ART did so at a CD4 count ,100 cells/mL (late start): 38% of all 326 patients and 45% of the 272 patients who fulfilled the ART eligibility criteria.
In the univariable analysis, patients having no form of employment were twice more likely to have a late start of ART than those who had some employment (P = 0.029). Age older than 40 years (P = 0.036) was negatively associated with late start of ART (Table 2) . Household wealth, distance of residence from the health center, and HIV status disclosure were not associated with late start of ART.
In the multivariable analysis, having no form of employment [adjusted OR (aOR): 1.9; 95% confidence interval (CI): 1.2 to 3.3] and being male (aOR: 2.4; 95% CI: 1.3 to 4.2) were strongly associated with late start of ART (Table 2) . Being married/cohabiting (aOR: 0.4; 95% CI: 0.2 to 0.9) and having signs of alcohol dependence (aOR: 0.4; 95% CI: 0.2 to 0.8) were associated with a significantly lower likelihood of a late ART start.
When we restricted the multivariable analysis to the 272 patients who met the Ugandan ART eligibility criteria, we found similar associations [aOR: 2.6 (95% CI: 1.4 to 4.6) for being unemployed, aOR: 1.8 (95% CI: 1.0 to 3.3) for male sex, aOR: 0.4 (95% CI: 0.2 to 0.8) for alcohol dependence], although marital status was no longer significantly predictive (P = 0.201, data not shown).
Late start may reflect late (presentation for the) eligibility decision but also delay in starting treatment after eligibility for ART was established. A start up to 28 days after eligibility is established is considered an acceptable delay, needed for counseling and arranging for support. Seventy-two (22%) patients started ART more than 28 days after eligibility was established, including 20 (16%) of 123 patients who started at CD4 ,100 per microliter and 52 (26%, P = 0.048) of 203 patients who started at CD4 $100 cells/mL. Among the 254 (78%) patients who started ART within 28 days of eligibility, the risk factors for late start of ART (n = 103) from multivariable analysis pointed in the same direction as in the primary analysis. The associations with late start were even more pronounced for male sex (aOR: 4.5; 95% CI: 2.2 to 9.0) and being unemployed (aOR: 2.6; 95% CI: 1.4 to 4.8) (Table 3) .
DISCUSSION
In this study, 38% of HIV patients initiated ART late, that is, at a CD4 count of ,100 cells/mL. Because 84% of the patients who started ART late did so within 28 days of the eligibility decision, this late start is mainly because of delays in establishing eligibility for ART. Unemployment, male sex, and absence of high alcohol consumption predicted late start of ART compared to patients starting at CD4 counts between 100 and 200 cells/mL or otherwise with WHO clinical stage 4. These risk factors may relate to patients presenting late with very low CD4 counts or to physicians delaying the decision to start ART; our study was unable to distinguish between these 2 types of delay.
Other studies from sub-Saharan Africa reported similar findings in different patient categories and settings. 16, 18 Our operational definition concerned patients with very advanced HIV disease. Patients who start ART late are known to miss out on the benefits of ART, that is, preventing AIDS or death or both. 27 This late start may be a result of patients having received their HIV diagnosis late. An earlier study carried out in the same clinics had shown that only 29% of patients with pulmonary tuberculosis had been tested and received test results for HIV infection during their interface with the health services. 28 The patients in our study had a baseline median CD4 count of 132 cells/mL, similar to that reported by Mills et al in 10 clinics in Uganda. 16 Seventy percent of our study population was female, similar to that observed in other studies. 16, 18 Our data show that male patients are more than 2 times more likely to start ART late compared with female patients. Earlier studies in the region showed male gender to be associated with not completing screening for ART and advanced disease presentation. 2, 18 Women probably have higher chances of being tested for HIV than men in settings such as programmes for the prevention of mother-to-child transmission of HIV.
We found unemployment to be strongly associated with late start of ART, as did a study carried out in a tertiary hospital in Mbarara, Uganda. 18 Patients who do not have some form of employment may also not have the means to reach health care providers earlier. Priorities of economic needs may outweigh the individual's desire to seek health care.
Frequent alcohol consumption has been associated with late presentation of HIV patients at HIV care facilities. 19 In our study, patients who exhibited signs of alcohol dependence seemed to be less likely to start ART late. Other studies have reported similar findings of alcohol consumption not associated with delay of start of ART. 18, 29 A possible explanation for this is the possibility of an increased clinician's suspicion when it comes to patients who drink heavily.
We did not find an association between late ART start and distance of residence from health center nor household wealth. Although there are disparities within parts of the city, health centers and private health units are within easy reach for all patients as opposed to the situation in rural settings. Access to social amenities in the urban setting where the study was done is fairly homogeneous. This possibly explains why household wealth did not have an effect on late start of ART.
The median interval from time of entering into HIV care program to start of ART of 105 days was much higher than the 33 days observed in a similar study in the region. 2 These findings raise the suspicion that part of the delay in starting ART may be because of late recognition of declining CD4 counts or deteriorating clinical status by the HIV care program. Health system delays need to be addressed, including the requirement for a patient to identify a treatment supporter before ART is started.
The secondary analysis after excluding the patients who initiated ART after 28 days from the day that the clinician recommended starting ART identified the same predictors of late start of ART as the primary analysis. This indicates that these predictors relate to the recommendations of starting ART rather than to operational challenges that may cause further delays in actual start of treatment after eligibility has been established.
Our study had some limitations. Only the most recent medical records were available. Recall bias could have influenced these results. Our definition for late start of ART considered a CD4 count ,100 cells/mL. In European or US settings, this would be regarded as "very late" rather than "late" start. Our study was carried out in government health facilities. The results could possibly have been different if private health facilities were included. However, as few studies on this subject have collected and analyzed data from governmentowned primary health centers, this can also be considered a strength of our study. Currently, much of the program support toward ART provision is channeled through government health facilities with the private sector playing a limited role.
CONCLUSIONS
A considerable proportion of patients in Kampala government health facilities started ART at very low CD4 counts. Male and unemployed patients were more likely and married/cohabitating patients and patients aged 40 years or older were less likely to start ART late. These risk factors may reflect patient delays but also health service delays.
